← Oncology Approval Tracker

FDA DECISION ·

Bendamustine Hydrochloride Injection (Baxter)

bendamustine hydrochloride · Baxter Healthcare

FDA approvalNew formulationChronic lymphocytic leukemia and indolent B-cell lymphoma
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Additional bendamustine injection for adults with CLL or indolent B-cell NHL that progressed during or within six months after rituximab-containing treatment.

LAMPGEN ANALYSIS

Why it matters

The FDA action authorizes another bendamustine presentation for the established oncology uses.

What research teams should watch

Check the presentation and product-specific preparation and confirm prior rituximab timing when applicable.

PRIMARY RECORDS

Sources